No increase in suicide in the early days of COVID pandemic
A new publication led by CHÉOS Scientist Dr. David Barbic compared suicide rates from the first phase of the pandemic to the previous 10 years
Read MoreApril 7, 2021
CHÉOS investigators and research support staff are responding to the COVID-19 pandemic. Current projects include examining mental wellness during a pandemic, the impact of school disruptions, treatment options for COVID-19 and identifying workplace risks that may increase the risk of transmission to paramedics. Our investigators have also shared their expertise in a number of areas related to the pandemic.
A new publication led by CHÉOS Scientist Dr. David Barbic compared suicide rates from the first phase of the pandemic to the previous 10 years
Read More
CHÉOS Statistician Dr. Terry Lee joined researchers investigating whether angiotensin receptor blockers and ACE inhibitors could be viable treatment options for COVID-19
Read More
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
As Dr. Amy Salmon continues to navigate the long-lasting effects of the virus, she is appreciative of the unique perspective it has brought to her work
Read More
Paramedics are the focus of a new COVID-19 study, led by CHÉOS Scientist Dr. Brian Grunau
Read More
As scientists around the world, including a team at St. Paul's Hospital, are racing to find an effective treatment for COVID-19, CHÉOS project managers are proud to be a small part of this global effort.
Read More